You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Sulthiame monotherapy for epilepsy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2014
|
| DOI | 10.1002/14651858.cd010062.pub2 |
| Pubmed ID | |
| Authors |
Philip Milburn-McNulty, Graham Powell, Graeme J Sills, Anthony G Marson |
| Abstract |
Epilepsy is a common neurological condition characterised by recurrent seizures. Sulthiame (STM) is widely used as an antiepileptic drug in Europe and Israel. In this review, we present a summary of evidence for the use of STM as monotherapy in epilepsy. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Ethiopia | 1 | 1% |
| South Africa | 1 | 1% |
| Unknown | 89 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 18% |
| Student > Bachelor | 15 | 16% |
| Researcher | 11 | 12% |
| Student > Ph. D. Student | 8 | 9% |
| Student > Doctoral Student | 5 | 5% |
| Other | 12 | 13% |
| Unknown | 24 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 43% |
| Nursing and Health Professions | 12 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Psychology | 3 | 3% |
| Computer Science | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 25 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 September 2014.
All research outputs
#15,704,137
of 25,655,374 outputs
Outputs from Cochrane database of systematic reviews
#11,058
of 13,151 outputs
Outputs of similar age
#124,346
of 235,987 outputs
Outputs of similar age from Cochrane database of systematic reviews
#208
of 241 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,987 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 241 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.